Loading...
No Data
TYRA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4 | Tyra Biosciences, Inc. (0001863127) (Issuer)
TYRA BIOSCIENCES, INC.: Information required of institutional investment managers pursuant to Section 13(f)
3 | Tyra Biosciences, Inc. (0001863127) (Issuer)
TYRA BIOSCIENCES, INC.: Quarterly report
10-Q | Tyra Biosciences, Inc. (0001863127) (Filer)
TYRA BIOSCIENCES, INC.: Events or Changes Between Quarterly Reports
8-K | Tyra Biosciences, Inc. (0001863127) (Filer)
TYRA BIOSCIENCES, INC.: Others
DEFA14A | Tyra Biosciences, Inc. (0001863127) (Filer)
TYRA BIOSCIENCES, INC.: Definitive proxy statements
DEF 14A | Tyra Biosciences, Inc. (0001863127) (Filer)
TYRA BIOSCIENCES, INC.: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
SC 13G | Tyra Biosciences, Inc. (0001863127) (Subject)
TYRA BIOSCIENCES, INC.: Information required of institutional investment managers pursuant to Section 13(f)
3 | Tyra Biosciences, Inc. (0001863127) (Issuer)
TYRA BIOSCIENCES, INC.: FY2021 Annual Report
10-K | Tyra Biosciences, Inc. (0001863127) (Filer)
TYRA BIOSCIENCES, INC.: Events or Changes Between Quarterly Reports
8-K | Tyra Biosciences, Inc. (0001863127) (Filer)